Emily M. Leproust - 14 Jun 2021 Form 4 Insider Report for Twist Bioscience Corp (TWST)

Role
President & CEO, Director
Signature
/s/ William Solis, as Attorney-in-Fact for Emily M. Leproust
Issuer symbol
TWST
Transactions as of
14 Jun 2021
Net transactions value
-$226,719
Form type
4
Filing time
16 Jun 2021, 17:20:52 UTC
Previous filing
24 May 2021
Next filing
06 Jul 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TWST Common Stock Sale $123,620 -1,100 -0.42% $112.38* 258,886 14 Jun 2021 Direct F1, F2
transaction TWST Common Stock Sale $56,651 -500 -0.19% $113.30* 258,386 14 Jun 2021 Direct F1, F3
transaction TWST Common Stock Sale $46,448 -400 -0.15% $116.12* 257,986 14 Jun 2021 Direct F1, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding TWST Employee Stock Option (right to buy) 230,794 14 Jun 2021 Common Stock 0 $8.82 Direct F5
holding TWST Employee Stock Option (right to buy) 266,539 14 Jun 2021 Common Stock 0 $26.66 Direct F6
holding TWST Employee Stock Option (right to buy) 131,290 14 Jun 2021 Common Stock 0 $23.33 Direct F7
holding TWST Employee Stock Option (right to buy) 95,699 14 Jun 2021 Common Stock 0 $5.95 Direct F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on September 16, 2020.
F2 Represents the weighted average sales price per share. The shares sold at prices ranging from $111.81 to $112.78 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
F3 Represents the weighted average sales price per share. The shares sold at prices ranging from $113.05 to $113.55 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
F4 Represents the weighted average sales price per share. The shares sold at prices ranging from $115.70 to $116.56 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
F5 The option is immediately exercisable. 10% of the shares subject to the option vested on September 28, 2017, 15% of the shares subject to the option vested on September 28, 2018, and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.
F6 20% of the shares subject to the option vested and became exercisable on October 31, 2019 and 1/60th of the shares subject to the option vest and become exercisable on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.
F7 25% of the shares subject to the option vested on October 24, 2020, and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.
F8 The option is immediately exercisable. 25% of the shares subject to the option vested on September 1, 2016 and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.